Yuniza; Melani; Ratna Maila Dewi Anggraini; Yenny Dian Andayani. Efficacy and Safety of IL-5 Pathway-Targeting Biologics (Mepolizumab, Reslizumab, Benralizumab) in the Management of Hypereosinophilic Syndromes: A Systematic Review and Meta-Analysis. OAIJMR 2025, 5, 1481-1500.